US court rules in favour of Warner Chilcott

Warner Chilcott has announced that it has received a decision from the United States District Court for the Southern District of Indiana concerning its patent litigation dispute with Teva Pharmaceuticals (Teva).

The case was initiated in response to an abbreviated new drug application (ANDA) filed by Teva to market a generic version of Sarafem, the US sales and marketing rights of which were acquired from Eli Lilly & Co. (Lilly) by Warner Chilcott in January 2003.